Fundraising Fox

Bioscience Equity Partners

Venture capital

Dubai Β· Late Stage Β· 1 people tracked

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Bioscience Equity Partners structures, anchors, and closes institutional capital transactions across two divisions. In life sciences, its affiliated anchor fund Antisoma Venture Capital anchors roughly half of each round for biotechnology, medical technology, and digital health companies, with the remainder syndicated across a consortium of sovereign and quasi-sovereign funds. Its Infrastructure & Sovereign Advisory division structures and executes infrastructure-grade transactions for governments, ministries, sovereign funds, and state-owned enterprises across energy, agricultural biotechnology, and defence-adjacent manufacturing. The firm runs every mandate from origination to close and engages only counterparties known to its consortium, declining unsolicited approaches.

Source: firm website, verified Aug 3, 2026.

Stage
Late Stage
HQ
Dubai, AE
Instruments
Equity Β· Debt
Founded
2011

Team Β· 1 people

from the firm's website

Frequently asked questions

What stage does Bioscience Equity Partners invest at?
Bioscience Equity Partners invests at the Late Stage stage.
What sectors does Bioscience Equity Partners focus on?
Bioscience Equity Partners focuses on Advanced Manufacturing, AgTech, Biotech, Defense Tech, Digital Health, Energy, Healthtech, Longevity, Medical Devices.
Where is Bioscience Equity Partners located?
Bioscience Equity Partners is headquartered in Dubai, AE.

Media Β· Podcasts & interviews

featuring the team

Inside the Mind of a Global Biotech Investor: Dr. George Syrmalis, CEO, Bioscience Equity Partners

Analyzing Healthcare by SCALE Community Β· George Syrmalis

Images

Bioscience Equity Partners photoBioscience Equity Partners photoBioscience Equity Partners photoBioscience Equity Partners photoBioscience Equity Partners photoBioscience Equity Partners photo

Similar investors

Featured in lists